Patient number | CD status prior to pregnancy | Pregnancy number/week | Indication for MR | Principal MRE findings | Clinical management | Clinical outcome | Pregnancy outcome |
---|---|---|---|---|---|---|---|
1 | 20 years duration | 1/23 | Clinical exacerbation of known CD | Phlegmon, sinus tract and fistula | Prednisone therapy and IV antibiotics | No improvement on medical treatment | |
Inflammatory phenotype | |||||||
Ileocolonic distribution | |||||||
No current treatment | |||||||
1/26 | Clinical exacerbation | Small abscess 3 weeks later | Abscess not accessible to drainage, conservative treatment with steroids and IV antibiotics | Clinical deterioration, surgical intervention one month post-delivery, including ileostomy and cecectomy. | Spontaneous VD at 34 weeks, healthy newborn | ||
2 | 9 years duration | 2/19 | Clinical exacerbation of known CD | Active disease, no complications, no obstruction | Addition of IV steroids | Clinical response and discharge | Spontaneous VD at 38 weeks, healthy newborn |
Inflammatory phenotype | |||||||
Ileocolonic distribution | |||||||
Tx: Azathioprine | |||||||
3 | 16 years duration | 1/31 | Clinical exacerbation of known CD new onset of cholestasis | Scant signs of active disease, no complications, no obstruction | UDCA and prednisone added to maintenance treatment with 6 MP | Improvement of CD symptoms, persistent cholestasis | Induced preterm vaginal delivery for cholestatsis at 35 weeks healthy newborn |
Fibrostenotic phenotype | |||||||
s/p ileocecectomy | |||||||
Ileocolonic distribution | |||||||
Tx: 6-MP | |||||||
4 | 15 years duration | 2/22 | Clinical exacerbation of known CD | Active disease phlegmon and fistulae | Enteral nutrition modulation a | Partial response phlegmon and fistulae in CT post- delivery, antibiotics: Adalimumab was after delivery | Spontaneous vaginal delivery at 38 weeks, healthy newborn |
Fibrostenotic and inflammatory phenotype | |||||||
Ileocolonic distribution | |||||||
Tx: Azathioprine | |||||||
5 | 4 years duration | 1/37 | Clinical exacerbation of known CD preeclampsia | Some signs of active disease, no complications | IV steroids and antibiotics | Preeclampsia Urgent delivery | Spontaneous onset of labor, vaginal delivery converted to C/S, at 37 weeks healthy newborn |
Inflammatory phenotype | |||||||
Inactive perianal disease | |||||||
Crohn’s colitis | |||||||
Tx: infliximab | |||||||
6 | 10 years duration | 2/20 | Recurrent abscess in right groin, fistula? | Phlegmon in RLQ fistula to right groin | IV and PO antibiotics and abscess drainage prior to MR | Clinical improvement | Spontaneous delivery, healthy newborn at week 38 |
Inflammatory phenotype | |||||||
Ileocolonic distribution | |||||||
Tx: Azathioprine | |||||||
7 | 2 years duration | 2/25 | Clinical exacerbation of known CD | Signs of active disease, new phlegmon in RLQ | Conservative treatment with steroids and IV antibiotics emergency cerclage | Temporary clinical improvement hypoalumiemia & anasarca | Spontaneous vaginal delivery at 28 weeks healthy very low birth weight newborn |
Inflammatory phenotype | |||||||
Ileocolonic distribution | |||||||
Tx: 6-MP and adalimumab | |||||||
8 | No known disease | 1/26 | Suspected CD | Bowel normal | No treatment | Abdominal symptoms resolved | Healthy twins newborns C/S at 32 w |
9 | No known disease | ?/11 | Uncertain diagnosis of UC, suspected CD | MRE signs of UC | NA | NA | Spontaneous delivery with a healthy newborn at week 41S |